Shorter radiation may spare side effects for prostate cancer patients

NCT ID NCT05038332

Recruiting now Symptom relief Sponsor: University of Michigan Rogel Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a shorter, more intense radiation course (SBRT, about 2 weeks) is gentler on quality of life than the standard 4-week course for men with prostate cancer who have had their prostate removed. About 136 men will be randomly assigned to one of the two schedules. The main goal is to compare bowel and urinary side effects two years after treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: radiation therapy
What this could lead to: If it works, this could show that a shorter, more intense radiation course (SBRT) causes fewer side effects and better quality of life than the standard longer course for prostate cancer patients after surgery.
What could go wrong: This is a small, early-phase trial (136 people) comparing two radiation schedules. It focuses on quality of life, not cancer control, so it may not change standard care. Side effects from SBRT could be worse for some patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

University of Michigan Rogel Cancer Center
RECRUITING

Ann Arbor, Michigan, 98107, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.